127 related articles for article (PubMed ID: 21507910)
1. Multiplex ligation-dependent probe amplification analysis is useful for diagnosing congenital adrenal hyperplasia but requires a deep knowledge of CYP21A2 genetics.
Concolino P; Mello E; Minucci A; Zuppi C; Capoluongo E
Clin Chem; 2011 Jul; 57(7):1079-80. PubMed ID: 21507910
[No Abstract] [Full Text] [Related]
2. Sequence analysis of CYP21A1P in a German population to aid in the molecular biological diagnosis of congenital adrenal hyperplasia.
Cantürk C; Baade U; Salazar R; Storm N; Pörtner R; Höppner W
Clin Chem; 2011 Mar; 57(3):511-7. PubMed ID: 21148302
[TBL] [Abstract][Full Text] [Related]
3. Multiplex ligation-dependent probe amplification (MLPA) assay for the detection of CYP21A2 gene deletions/duplications in congenital adrenal hyperplasia: first technical report.
Concolino P; Mello E; Toscano V; Ameglio F; Zuppi C; Capoluongo E
Clin Chim Acta; 2009 Apr; 402(1-2):164-70. PubMed ID: 19263525
[TBL] [Abstract][Full Text] [Related]
4. Multiplex ligation-dependent probe amplification assay for diagnosis of congenital adrenal hyperplasia.
Jang JH; Jin DK; Kim JH; Tan HK; Kim JW; Lee SY; Ki CS; Park HD
Ann Clin Lab Sci; 2011; 41(1):44-7. PubMed ID: 21325254
[TBL] [Abstract][Full Text] [Related]
5. Development of CYP21A2 Genotyping Assay for the Diagnosis of Congenital Adrenal Hyperplasia.
Prado MJ; de Castro SM; Kopacek C; de Mello MP; Rispoli T; Grandi T; da Silva CMD; Rossetti MLR
Mol Diagn Ther; 2017 Dec; 21(6):663-675. PubMed ID: 28819757
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive mutation analysis of the CYP21A2 gene: an efficient multistep approach to the molecular diagnosis of congenital adrenal hyperplasia.
Xu Z; Chen W; Merke DP; McDonnell NB
J Mol Diagn; 2013 Nov; 15(6):745-53. PubMed ID: 24071710
[TBL] [Abstract][Full Text] [Related]
7. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
[TBL] [Abstract][Full Text] [Related]
8. CYP21A2 mutation analysis in Korean patients with congenital adrenal hyperplasia using complementary methods: sequencing after long-range PCR and restriction fragment length polymorphism analysis with multiple ligation-dependent probe amplification assay.
Hong G; Park HD; Choi R; Jin DK; Kim JH; Ki CS; Lee SY; Song J; Kim JW
Ann Lab Med; 2015 Sep; 35(5):535-9. PubMed ID: 26206692
[TBL] [Abstract][Full Text] [Related]
9. Detection of a frequent duplicated CYP21A2 gene carrying a Q318X mutation in a general population with quantitative PCR methods.
Kharrat M; Riahi A; Maazoul F; M'rad R; Chaabouni H
Diagn Mol Pathol; 2011 Jun; 20(2):123-7. PubMed ID: 21532487
[TBL] [Abstract][Full Text] [Related]
10. Clinical phenotype and mutation spectrum of the CYP21A2 gene in patients with steroid 21-hydroxylase deficiency.
Choi JH; Jin HY; Lee BH; Ko JM; Lee JJ; Kim GH; Jung CW; Lee J; Yoo HW
Exp Clin Endocrinol Diabetes; 2012 Jan; 120(1):23-7. PubMed ID: 22020670
[TBL] [Abstract][Full Text] [Related]
11. Genetics of congenital adrenal hyperplasia and genotype-phenotype correlation.
Narasimhan ML; Khattab A
Fertil Steril; 2019 Jan; 111(1):24-29. PubMed ID: 30611409
[TBL] [Abstract][Full Text] [Related]
12. High-resolution melting curve (HRM) analysis to establish CYP21A2 mutations converted from the CYP21A1P in congenital adrenal hyperplasia.
Lin YC; Lin YC; Liu TC; Chang JG; Lee HH
Clin Chim Acta; 2011 Oct; 412(21-22):1918-23. PubMed ID: 21762683
[TBL] [Abstract][Full Text] [Related]
13. Lack of genotypephenotype correlation in congenital adrenal hyperplasia due to a CYP21A2-like gene.
Leccese A; Longo V; Dimatteo C; De Girolamo G; Trunzo R; D'Andrea G; Bafunno V; Margaglione M; Santacroce R
Clin Chim Acta; 2014 Nov; 437():48-51. PubMed ID: 25025300
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of copy number variation of
Gao YJ; Yu BQ; Lu L; Wu XY; Mao JF; Wang X; Tong AL; Chen S; Nie M
Zhonghua Yi Xue Za Zhi; 2019 Dec; 99(48):3765-3769. PubMed ID: 31874511
[No Abstract] [Full Text] [Related]
15. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
Fujieda K; Mukai T
Nihon Rinsho; 2004 Feb; 62(2):361-7. PubMed ID: 14968546
[TBL] [Abstract][Full Text] [Related]
16. CYP21A2 genetic profile in 14 Egyptian children with suspected congenital adrenal hyperplasia: a diagnostic challenge.
Elmougy F; Sharaf S; Hafez M; Khattab A; Abou-Yousef H; Elsharkawy M; Baz H; Ekladious S; Sherif B; Musa N; Elshiwy Y; Afif A; Abdullatif M; Thabet G; Rady N; Ibrahim A; Soliman H
Ann N Y Acad Sci; 2018 Mar; 1415(1):11-20. PubMed ID: 29266270
[TBL] [Abstract][Full Text] [Related]
17. In vitro gene amplification for prenatal diagnosis of congenital adrenal hyperplasia.
Rumsby G; Honour JW
J Med Genet; 1990 Nov; 27(11):676-8. PubMed ID: 2277381
[TBL] [Abstract][Full Text] [Related]
18. Congenital Adrenal Hyperplasia (CAH) due to 21-Hydroxylase Deficiency: A Comprehensive Focus on 233 Pathogenic Variants of CYP21A2 Gene.
Concolino P; Costella A
Mol Diagn Ther; 2018 Jun; 22(3):261-280. PubMed ID: 29450859
[TBL] [Abstract][Full Text] [Related]
19. A simple and robust quantitative PCR assay to determine CYP21A2 gene dose in the diagnosis of 21-hydroxylase deficiency.
Parajes S; Quinterio C; Domínguez F; Loidi L
Clin Chem; 2007 Sep; 53(9):1577-84. PubMed ID: 17634211
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetics of 21-hydroxylase deficiency.
Wedell A
Endocr Dev; 2011; 20():80-87. PubMed ID: 21164261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
